Correspondence 0001641172-25-001319 from Microbot Medical Inc. (MBOT)
Microbot Medical Inc.
Date: March 28, 2025 · CIK: 0000883975 · Accession: 0001641172-25-001319
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285690
Letter
Microbot Medical Inc.
Derby St., Bld. 27
Hingham, MA 02043
March 28, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
F. St., N.E.
Washington, D.C. 20549
Re: Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-285690)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Microbot Medical Inc. hereby requests the acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-285690) so that it will become effective on Tuesday, April 1, 2025 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
Very
truly yours,
Microbot
Medical Inc.
Show Raw Text
CORRESP 1 filename1.htm Microbot Medical Inc. 175 Derby St., Bld. 27 Hingham, MA 02043 March 28, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. St., N.E. Washington, D.C. 20549 Re: Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-285690) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Microbot Medical Inc. hereby requests the acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-285690) so that it will become effective on Tuesday, April 1, 2025 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable. Very truly yours, Microbot Medical Inc. By: /s/ Harel Gadot Name: Harel Gadot Title: CEO, President and Chairman